Global /India /Healthcare /Biotechnology /FABTECH

Fabtech Technologies Ltd.

FABTECH

• NSE: FABTECH • Delayed

171.22INR -0.8%

1.79 USD

As of 5 June 2026, Fabtech Technologies Ltd. has a market cap of $79.49M USD, ranking #27201 globally and #1689 in India. It ranks #2448 in the Healthcare sector, and #474 in the Biotechnology industry.

Global Rank

27201

Country Rank

1689

Sector Rank

2448

Industry Rank

474

Key Stats

Market Cap

$79.49MUSD

7.61B INR

Enterprise Value

$60.1MUSD

5.75B INR

Revenue (TTM)

$45.05MUSD

4.31B INR

EBITDA (TTM)

$5.8MUSD

555.56M INR

Net Income (TTM)

$4.01MUSD

383.58M INR

EBITDA Margin

13%

Profit Margin

8.9%

PE Ratio

17.1

PS Ratio

1.8

PB Ratio

1.8

EV/EBITDA

10.3

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Biotechnology

CEO

Ashwani Singh open_in_new

Employees

187

Founded

2001

Website

fabtechnologies.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	9.4%	11%	5.2%	-33%	-13%	-22%	-22%	-22%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	FABTECH ISIN: INE0HF201011 Shares Out.: Shares Outstanding: 44.451M¹ Shares Float: 11.049M² TV: TradingView: NSE: FABTECH SA: Stock Analysis: NSE: FABTECH YF: Yahoo Finance: FABTECH.NS GF: Google Finance: NSE: FABTECH BA: Barron's: FABTECH MS: Morningstar: XNSE: FABTECH	171.22 INR	TV: TradingView: NSE: FABTECH SA: Stock Analysis: NSE: FABTECH YF: Yahoo Finance: FABTECH.NS GF: Google Finance: NSE: FABTECH BA: Barron's: FABTECH MS: Morningstar: XNSE: FABTECH
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	FABTECH ISIN: INE0HF201011 TV: TradingView: BSE: FABTECH SA: Stock Analysis: BOM: FABTECH YF: Yahoo Finance: FABTECH.BO GF: Google Finance: BOM: FABTECH BA: Barron's: FABTECH MS: Morningstar: XBOM: FABTECH	153.65 INR	TV: TradingView: BSE: FABTECH SA: Stock Analysis: BOM: FABTECH YF: Yahoo Finance: FABTECH.BO GF: Google Finance: BOM: FABTECH BA: Barron's: FABTECH MS: Morningstar: XBOM: FABTECH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Fabtech Technologies Ltd.

Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.

Similar Companies

Industry: Biotechnology (India)

Name	Market Cap (USD) diff.	PE	Country
Anthem Biosciences Ltd. NSE: ANTHEM	$4.55B 435.39B INR 6K%	90.4	India
Rubicon Research Ltd. NSE: RUBICON	$1.68B 160.71B INR 2K%	74.8	India
Akums Drugs and Pharmaceuticals Ltd. NSE: AKUMS	$869.35M 83.24B INR 994%	26.2	India
Titan Biotech Ltd. BSE: TITANBIO	$190.84M 18.27B INR 140%	-	India
Fermenta Biotech Ltd. NSE: FERMENTA	$96.13M 9.2B INR 21%	10.6	India
Haleos Labs Ltd. NSE: SMSLIFE	$47.39M 4.54B INR -40%	22.9	India

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 229K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 201K%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 60K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 56K%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 54K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 54K%	37.2	Switzerland

chevron_leftBack